Fangzhou Inc. (6086.HK), a provider of AI-powered Internet healthcare solutions, announced a strategic collaboration with Youcare Pharmaceutical Group. This partnership is designed to accelerate the digital transformation of chronic disease services in China, applying artificial intelligence to improve accessibility, efficiency, and precision in patient care.
Through this agreement, the two companies will jointly advance the modernization of chronic disease management by integrating digital innovation with specialized medical expertise. Their shared vision is to build a comprehensive, full-lifecycle health management ecosystem that supports patients across diverse therapeutic areas while aligning with China's national push toward digitalized and specialized healthcare.
The collaboration will focus on two primary areas. First, Fangzhou and Youcare will co-develop digital systems that combine Youcare's pharmaceutical innovation and clinical knowledge with Fangzhou's AI-driven platforms. This integration aims to create an intelligent, digitally enabled chronic disease management system.
The partnership will expand health management services by exploring new collaboration models in key therapeutic fields such as cardiovascular, infectious, and endocrine diseases. Leveraging AI, the companies intend to broaden patient access to high-quality medicines and professional care, ultimately strengthening the delivery of full-cycle health management solutions.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.